Literature DB >> 21802588

EUS and magnetic resonance imaging in the staging of rectal cancer: a prospective and comparative study.

Glòria Fernández-Esparrach1, Juan R Ayuso-Colella, Oriol Sendino, Mario Pagés, Miriam Cuatrecasas, Maria Pellisé, Joan Maurel, Carmen Ayuso-Colella, Begoña González-Suárez, Josep Llach, Antoni Castells, Angels Ginès.   

Abstract

BACKGROUND: Accurate locoregional staging is crucial in rectal cancer for deciding patient management because the administration of neoadjuvant therapy depends on it. EUS and magnetic resonance imaging (MRI) are used indistinctly in the pretherapeutic workup of rectal cancer.
OBJECTIVE: To prospectively compare the performance of EUS and MRI in the locoregional staging of rectal cancer in a large series of patients.
DESIGN: Prospective and comparative study.
SETTING: Tertiary center. PATIENTS: Patients with histologically proven rectal cancer.
INTERVENTIONS: EUS and MRI were performed in all patients by a different operator unaware of the results of the other procedure. MAIN OUTCOME MEASUREMENTS: Epidemiological, clinical, radiological, and echographic variables were evaluated. Pathological examination of the surgical specimen was used as the criterion standard.
RESULTS: Ninety patients (54 men and 36 women with a mean age of 68 ± 12 years; range 33-87 years) constitute the final sample of this study. Most of the tumors were stages T2-T3 (85%; 95% CI, 77%-92%). Twenty of them (22%; 95% CI, 14%-32%) were stenotic and 24 (27%; 95% CI, 18%-37%) had polypoid morphology. The accuracy of T staging was very similar for EUS and MRI for stage T2 (76%; 95% CI, 65%-84% and 77%; 95% CI, 67%-85%, respectively; P = not significant) and stage T3 (76%; 95% CI, 65%-84% and 83%, 95% CI, 73%-90%, respectively; P = not significant). MRI was not able to visualize any T1 tumor, whereas EUS understaged all T4 tumors. The univariate analysis showed that the polypoid morphology of the tumor inversely correlated with T staging on MRI. The accuracy of MRI for N staging was higher than that of EUS, although the difference did not reach statistical significance (79%; 95% CI, 65%-88% and 65%; 95% CI, 51%-78%, respectively). When performing the univariate analysis to assess the reasons for this difference, the presence of a stenotic tumor was the only parameter significantly related to a poorer performance of EUS in N staging. LIMITATIONS: The small number of early and locally advanced lesions.
CONCLUSIONS: EUS and MRI have similar accuracy in the T and N staging in rectal cancer. The presence of stenosis and polypoid morphology is inversely associated with accuracy for either EUS or MRI.
Copyright © 2011 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21802588     DOI: 10.1016/j.gie.2011.03.1257

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  26 in total

Review 1.  MRI Local Staging and Restaging in Rectal Cancer.

Authors:  Gregory dePrisco
Journal:  Clin Colon Rectal Surg       Date:  2015-09

2.  Quality indicators for EUS.

Authors:  Sachin Wani; Michael B Wallace; Jonathan Cohen; Irving M Pike; Douglas G Adler; Michael L Kochman; John G Lieb; Walter G Park; Maged K Rizk; Mandeep S Sawhney; Nicholas J Shaheen; Jeffrey L Tokar
Journal:  Am J Gastroenterol       Date:  2014-12-02       Impact factor: 10.864

Review 3.  Role of endoscopic ultrasonography in the loco-regional staging of patients with rectal cancer.

Authors:  Pietro Marone; Mario de Bellis; Valentina D'Angelo; Paolo Delrio; Valentina Passananti; Elena Di Girolamo; Giovanni Battista Rossi; Daniela Rega; Maura Claire Tracey; Alfonso Mario Tempesta
Journal:  World J Gastrointest Endosc       Date:  2015-06-25

4.  Learning curve of endorectal ultrasonography in preoperative staging of rectal carcinoma.

Authors:  Zuo-Liang Liu; Tong Zhou; Xiao-Bo Liang; Jun-Jie Ma; Guang-Jun Zhang
Journal:  Mol Clin Oncol       Date:  2014-07-17

Review 5.  Beyond Histologic Staging: Emerging Imaging Strategies in Colorectal Cancer with Special Focus on Magnetic Resonance Imaging.

Authors:  Tyler J Fraum; Joseph W Owen; Kathryn J Fowler
Journal:  Clin Colon Rectal Surg       Date:  2016-09

6.  Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation.

Authors:  Xabier García-Albéniz; Rosa Gallego; Ralf Dieter Hofheinz; Gloria Fernández-Esparrach; Juan Ramón Ayuso-Colella; Josep Antoni Bombí; Carles Conill; Miriam Cuatrecasas; Salvadora Delgado; Angels Ginés; Rosa Miquel; Mario Pagés; Estela Pineda; Verónica Pereira; Aarón Sosa; Oscar Reig; Iván Victoria; Luis Feliz; Antonio María de Lacy; Antoni Castells; Iris Burkholder; Andreas Hochhaus; Joan Maurel
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

7.  Value of endorectal ultrasonography in measuring the extent of mesorectal invasion and substaging of T3 stage rectal cancer.

Authors:  Guangxi Zhong; Yi Xiao; Weixun Zhou; Weidong Pan; Qingli Zhu; Jing Zhang; Yuxin Jiang
Journal:  Oncol Lett       Date:  2017-09-06       Impact factor: 2.967

8.  Transrectal ultrasound and magnetic resonance imaging measurement of extramural tumor spread in rectal cancer.

Authors:  Søren R Rafaelsen; Chris Vagn-Hansen; Torben Sørensen; John Pløen; Anders Jakobsen
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

Review 9.  Watch and Wait: Is Surgery Always Necessary for Rectal Cancer?

Authors:  Alexander T Hawkins; Steven R Hunt
Journal:  Curr Treat Options Oncol       Date:  2016-05

10.  Forward-viewing radial-array echoendoscope for staging of colon cancer beyond the rectum.

Authors:  Pradermchai Kongkam; Sittikorn Linlawan; Satimai Aniwan; Narisorn Lakananurak; Suparat Khemnark; Chucheep Sahakitrungruang; Jirawat Pattanaarun; Supakij Khomvilai; Naruemon Wisedopas; Wiriyaporn Ridtitid; Manoop S Bhutani; Pinit Kullavanijaya; Rungsun Rerknimitr
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.